Document is current
Any future updates will be listed below
-
Authors
Faurholt-Jepsen, Maria http://orcid.org/0000-0002-0462-6444
Miskowiak, Kamilla Woznica
Frost, Mads
Christensen, Ellen Margrethe
Þórarinsdóttir, Helga
Bardram, Jakob Eyvind
Vinberg, Maj
Kessing, Lars Vedel
-
Funding
Funding for this research was provided by:
All founding is provided in the manuscript (See manuscript)
- License Information
-
More Information
Article History
Received: 21 February 2020
Accepted: 17 September 2020
First Online: 30 October 2020
Ethics approval and consent to participate
: The trials were approved by the Regional Ethics Committee in the Capital Region of Denmark (H-2-2011-056, H-2-2014-059 and H-7-2014-007) and the Danish Data protection agency (2013-41-1710). The law on handling of personal data was respected. Prior to commencement the trials were registered at ClinicalTrials.gov (NCT01446406 and NCT02221336). Electronic data collected from the smartphones were stored at a secure server at Concern IT, Capital Region, Denmark (I-suite number RHP-292 2011-03). The trial complied with the Helsinki Declaration of 1975, as revised in 2008.
: Not applicable.
: MFJ and HÞ have no conflicts of interest. KWM has been a consultant for Lundbeck, Allergan and Janssen within the last three years. MF and JEB are co-founders and shareholders in Monsenso ApS. EMC has been a consultant for Eli Lilly, Astra Zeneca, Servier, Bristol-Myers Squibb, Lundbeck, and Medilink. MV has been a consultant for Lundbeck within the last 3 years. LVK has during recent 3 years been a consultant for Sunovion and Lundbeck.
